| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.867 | 15 | 0 | 1986 | 2000 | |||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1995 | 2018 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2005 | 2017 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2002 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1997 | 2008 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1997 | 2008 | |||||||||
|
MIR155 host gene | 0.617 | 0.615 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2003 | 2007 | |||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1997 | 2008 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2010 | 2014 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1989 | 2008 | |||||||||
|
immunoglobulin kappa locus | 0.647 | 0.462 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2018 | |||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
disease | 0.400 | None | 1.000 | 4 | 6 | 2010 | 2017 | |||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2008 | |||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2008 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2005 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | |||||||||
|
interferon lambda 4 (gene/pseudogene) | 0.670 | 0.577 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | |||||||||
|
T helper type 2 locus control region associated RNA | 0.751 | 0.385 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2014 | |||||||||
|
prostate cancer associated transcript 2 | 0.751 | 0.462 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
uncharacterized LOC105379528 | 0.617 | 0.615 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2002 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2009 | |||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
immunoglobulin lambda locus | 0.659 | 0.346 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2016 | |||||||||
|
immunoglobulin heavy chain variable region | 0.617 | 0.615 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2002 |